Back
Splash Beverage Group Vs. Keros Therapeutics Industry Stock Comparison
Sell
26
SBEV
Splash Beverage Group
Last Price:
$3.49
Seasonality Move:
70.71%
Sell
18
KROS
Keros Therapeutics
Last Price:
$13.41
Seasonality Move:
-0.3%
Sell
26
Splash Beverage Group (SBEV)
is a Sell
Is Splash Beverage Group a Buy, Sell or Hold?
-
The current Splash Beverage Group [SBEV] share price is $3.42. The Score for SBEV is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
SBEV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
-
The current Keros Therapeutics [KROS] share price is $13.34. The Score for KROS is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
KROS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
SBEV Stock Price Chart
What is Splash Beverage Group's stock price today?
-
The Splash Beverage Group share price today is $3.42The current trend is relatively stagnant and SBEV is experiencing selling pressure, which indicates risk of future bearish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $13.34Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
SBEV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 47.96 | Sell |
Chaikin Money Flow: | -10822 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.88 - 3.9) | Buy |
Bollinger Bands (100): | (2.57 - 6.37) | Sell |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 40.48 | Sell |
Chaikin Money Flow: | -290102 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.42 - 14.54) | Sell |
Bollinger Bands (100): | (10.98 - 14.22) | Buy |
SBEV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.32 | Buy |
20-day SMA: | 3.3 | Buy |
50-day SMA: | 4.63 | Sell |
200-day SMA: | 6.5 | Sell |
8-day EMA: | 3.42 | Buy |
20-day EMA: | 3.45 | Sell |
50-day EMA: | 3.95 | Sell |
200-day EMA: | 7 | Sell |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.54 | Sell |
20-day SMA: | 13.89 | Sell |
50-day SMA: | 14.05 | Sell |
200-day SMA: | 28.02 | Sell |
8-day EMA: | 13.51 | Sell |
20-day EMA: | 13.72 | Sell |
50-day EMA: | 13.81 | Sell |
200-day EMA: | 23.69 | Sell |
Splash Beverage Group Earnings Growth & SBEV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.60 per share, and a decrease next year of $0.80 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.03 per share, an increase this year of $4.50 per share, and a decrease next year of $4.46 per share.
Splash Beverage Group Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |